Activation and Characterization of Lanthomicins A-C by Promoter Engineering in Streptomyces chattanoogensis L10.
Ontology highlight
ABSTRACT: The emergence of drug resistance highlights the importance of new drug discovery. Microbial secondary metabolites encoded in biosynthetic gene clusters (BGCs) are a prolific source of drugs, whereas most of these BGCs are cryptic. Thus, taking strategies to activate these cryptic BGCs is of great importance for potential drug discovery. In this work, three novel pentangular polyphenols lanthomicin A-C were identified by activating a cryptic aromatic polyketide BGC through promoter engineering combined with optimization of fermentation conditions. We further confirmed the involvement of lanthomicin (ltm) BGC in biosynthesis by CRISPR-Cpf1-assisted gene editing. Based on functional analysis of homologous genes, a putative biosynthetic pathway was proposed for the three lanthomicins. P
SUBMITTER: Liu XF
PROVIDER: S-EPMC9127795 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA